A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.
Kirsten Jacobs, PhD
Advertisement
Chief Strategy Officer, PharmaLex, a Cencora company
Articles by Kirsten Jacobs, PhD
Amid shifting operating dynamics in recent years, demands for external expertise have fluctuated—leaving those arrangements that mix innovation and agility likely to win out in pharma decision-making.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bob Mauch: Strengthening the Chain
2
Novo Nordisk Stock Reacts to Recent Board Changes
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
